Mitral Regurgitation Quantification Using Dual-venc 4D flow MRI and Deep learning
Mitral Regurgitation Quantification Using Dual-venc 4D flow MRI and Deep learning
批准号:
10648495
负责人:
Jeesoo Lee
金额:
$20.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-15 至 2025-07-31
关键词:
3-Dimensional4D MRIAccelerationAddressAffectAgreementAreaBlood Flow VelocityBlood flowCardiacCessation of lifeClassificationClinicalCompensationComplexCoupledDataData SetDetectionDiseaseEchocardiographyEnrollmentEvaluationHeartHeart failureImageIn VitroLearningLeft atrial structureLesionMagnetic Resonance ImagingManualsMeasurementMeasuresMethodsMitral Valve InsufficiencyModelingMorphologyNatureNoiseOutputPatientsPhasePhysiologic pulsePlayPopulationProcessPulmonary valve structureReportingReproducibilityResolutionRiskRoleScanningSchemeSeveritiesSeverity of illnessShunt DeviceSiteStroke VolumeTechniquesTestingTimeTrainingTricuspid valve structureUncertaintyVisualizationWorkaccurate diagnosticsaortic valvecardiac magnetic resonance imagingclinical applicationclinical translationdeep learningdesigndetection methodhealthy volunteerhemodynamicshigh riskimaging modalityimprovedin vivoinnovationlearning networkmultitasknovelpatient stratificationresearch clinical testingrisk stratificationsuccessthree-dimensional visualizationtooltranslational approachtreatment planning
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Mitral valvular regurgitation (MVR) is one of the most common valvular diseases affecting over 5% of the U.S.
population. Timely and accurate assessment of MVR is crucial for these patients since MVR worsens over time
and untreated severe MVR significantly increases risk of heart failure and death. Currently, echocardiography
(echo) is the mainstay imaging modality for MVR where quantitation of MVR flow plays an instrumental role in
determining disease severity. However, inherent weaknesses of echo (2D acquisition, 1-directional velocity
measurements) limit quantification precision due to complex MVR hemodynamics characterized as a high-
velocity (4-6 m/s), heterogeneous (eccentric/multiple/non-holosystolic jets) flow jets with dynamically changing
mitral orifice morphology. Cardiac MRI (CMR) can be used to indirectly quantify MVR flow volume based on
differences in stroke volumes measured at different sites, however, errors in each measurement are amplified
due to subtraction and is inapplicable in patients with shunt flows and/or multiple valvular lesions. Further,
discordance between CMR and echo has consistently been reported suggesting a need for an accurate and
reliable quantitative technique.
4D flow MRI provides unique access to 4D (3D+time) intra-cardiac blood flow enabling “direct” quantification of
MVR jet flSow dynamics free from limitations in conventional echo- and CMR-based methods. However, clinical
translation of this approach remains challenging for two reasons. One is that a high velocity encoding sensitivity
(venc) of 4-6 m/s is required for conventional single-venc 4D flow MRI to capture high peak MVR flow jet velocity.
This limits velocity dynamic range of 4D flow MRI and thus, resulting in poor flow visualization and increased
flow quantification uncertainty. The other is that post-processing requires manual and cumbersome detection of
MVR flow jet in a 3D whole heart over a cardiac cycle, plane placement and jet contouring over many timeframes
limiting measurement reproducibility. This proposal seeks to address these limitations by developing a fast dual-
venc 4D flow MRI technique optimized for MVR flow velocity acquisition and second, a deep learning technique
for detection and segmentation of 4D MVR flow jet to fully automate MVR flow quantification process. The
specific objectives are: (1) to optimize CS dual-venc 4D flow MRI using in-vitro pulsatile MVR flow jet models,
(2) to validate the dual-venc 4D flow MRI in 60 MVR patients against echo and CMR acquired on the same-day
and (3) to develop a deep learning network to fully automate MVR flow quantification pipeline.
This project will generate a reproducible and accurate quantitative approach for clinical evaluation of MVR. Our
framework enjoys multiple innovations in imaging, deep learning, and clinical application. Lessons learned from
this should be applicable to quantification of other valvular regurgitant lesions, thus greatly expanding the impact
of this work.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金